Baidu
map

Circulation:提高男性心肺适应性可减少死亡危险

2011-12-12 MedSci原创 MedSci原创

12月6日发表在《循环》(Circulation 2011;124:2486-2490)杂志上的美国一项有氧运动中心纵向研究显示,保持或改善适应性与男性全因和心血管疾病死亡危险较低有关。预防与年龄相关的适应性减低对于长寿很重要,这与体质指数(BMI)无关。 研究者在至少2次医学体检中评价了14356名平均年龄为44岁的男性适应性改变和BMI独立及联合与全因和心血管疾病死亡率的关系。适应性通过

12月6日发表在《循环》(Circulation 2011;124:2486-2490)杂志上的美国一项有氧运动中心纵向研究显示,保持或改善适应性与男性全因和心血管疾病死亡危险较低有关。预防与年龄相关的适应性减低对于长寿很重要,这与体质指数(BMI)无关。

研究者在至少2次医学体检中评价了14356名平均年龄为44岁的男性适应性改变和BMI独立及联合与全因和心血管疾病死亡率的关系。适应性通过最大平板试验代谢当量(MET)评估。

分析显示,在末次体检后随访11.4年,受试者发生了914例全因死亡和300例心血管死亡。在包含BMI变化的多变量分析中,与适应性减退者相比,适应性稳定不变者的全因死亡和心血管死亡危险比分别为0.70和0.73,而适应性增加者为0.61和0.58。

MET每改善1,全因死亡和心血管死亡危险会分别降低15%和19%。校正可能的混杂因素和适应性变化后,BMI的变化与全因死亡和心血管死亡不相关。在复合分析中,不考虑BMI,适应性减退的男性有较高的全因死亡和心血管死亡危险。(生物谷bioon.com)

延伸阅读:

EHJ:高强度耐力训练引发心脏损伤

Circulation:提高男性心肺适应性可减少死亡危险

EJAP:短时高强度锻炼 远离糖尿病

CIRCULATION:长期强化运动训练大鼠模型的心脏致心律失常性重构

AIM:瑜伽可改善慢性腰痛患者的功能

2002年ACCAHA运动试验指南

链接:doi:10.1161/​CIRCULATIONAHA.111.038422
Long-Term Effects of Changes in Cardiorespiratory Fitness and Body Mass Index on All-Cause and Cardiovascular Disease Mortality in Men

Duck-chul Lee, PhD; Xuemei Sui, MD, MPH; Enrique G. Artero, PhD; I-Min Lee, MBBS, MPH, ScD; Timothy S. Church, MD, PhD; Paul A. McAuley, PhD; Fatima C. Stanford, MD, MPH; Harold W. Kohl III, PhD, MSPH; Steven N. Blair, PED
Background—The combined associations of changes in cardiorespiratory fitness and body mass index (BMI) with mortality remain controversial and uncertain.
Methods and Results—We examined the independent and combined associations of changes in fitness and BMI with all-cause and cardiovascular disease (CVD) mortality in 14 345 men (mean age 44 years) with at least 2 medical examinations. Fitness, in metabolic equivalents (METs), was estimated from a maximal treadmill test. BMI was calculated using measured weight and height. Changes in fitness and BMI between the baseline and last examinations over 6.3 years were classified into loss, stable, or gain groups. During 11.4 years of follow-up after the last examination, 914 all-cause and 300 CVD deaths occurred. The hazard ratios (95% confidence intervals) of all-cause and CVD mortality were 0.70 (0.59–0.83) and 0.73 (0.54–0.98) for stable fitness, and 0.61 (0.51–0.73) and 0.58 (0.42–0.80) for fitness gain, respectively, compared with fitness loss in multivariable analyses including BMI change. Every 1-MET improvement was associated with 15% and 19% lower risk of all-cause and CVD mortality, respectively. BMI change was not associated with all-cause or CVD mortality after adjusting for possible confounders and fitness change. In the combined analyses, men who lost fitness had higher all-cause and CVD mortality risks regardless of BMI change.
Conclusions—Maintaining or improving fitness is associated with a lower risk of all-cause and CVD mortality in men. Preventing age-associated fitness loss is important for longevity regardless of BMI change.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1684367, encodeId=8fa8168436eb1, content=<a href='/topic/show?id=dfae5133e1d' target=_blank style='color:#2F92EE;'>#心肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51337, encryptionId=dfae5133e1d, topicName=心肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e128082444, createdName=aids222, createdTime=Fri Feb 24 00:12:00 CST 2012, time=2012-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442790, encodeId=53971442e90ea, content=<a href='/topic/show?id=4198633567d' target=_blank style='color:#2F92EE;'>#死亡危险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63356, encryptionId=4198633567d, topicName=死亡危险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63604994803, createdName=1696533704_45270455, createdTime=Wed Dec 14 14:12:00 CST 2011, time=2011-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556382, encodeId=92a0155638261, content=<a href='/topic/show?id=1f525136920' target=_blank style='color:#2F92EE;'>#心肺适应性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51369, encryptionId=1f525136920, topicName=心肺适应性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dceb14754757, createdName=cnxcy, createdTime=Wed Dec 14 14:12:00 CST 2011, time=2011-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620990, encodeId=aaf216209907a, content=<a href='/topic/show?id=dccc94e01c9' target=_blank style='color:#2F92EE;'>#适应性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94701, encryptionId=dccc94e01c9, topicName=适应性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b13a20191510, createdName=huhuaidong394, createdTime=Wed Dec 14 14:12:00 CST 2011, time=2011-12-14, status=1, ipAttribution=)]
    2012-02-24 aids222
  2. [GetPortalCommentsPageByObjectIdResponse(id=1684367, encodeId=8fa8168436eb1, content=<a href='/topic/show?id=dfae5133e1d' target=_blank style='color:#2F92EE;'>#心肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51337, encryptionId=dfae5133e1d, topicName=心肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e128082444, createdName=aids222, createdTime=Fri Feb 24 00:12:00 CST 2012, time=2012-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442790, encodeId=53971442e90ea, content=<a href='/topic/show?id=4198633567d' target=_blank style='color:#2F92EE;'>#死亡危险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63356, encryptionId=4198633567d, topicName=死亡危险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63604994803, createdName=1696533704_45270455, createdTime=Wed Dec 14 14:12:00 CST 2011, time=2011-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556382, encodeId=92a0155638261, content=<a href='/topic/show?id=1f525136920' target=_blank style='color:#2F92EE;'>#心肺适应性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51369, encryptionId=1f525136920, topicName=心肺适应性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dceb14754757, createdName=cnxcy, createdTime=Wed Dec 14 14:12:00 CST 2011, time=2011-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620990, encodeId=aaf216209907a, content=<a href='/topic/show?id=dccc94e01c9' target=_blank style='color:#2F92EE;'>#适应性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94701, encryptionId=dccc94e01c9, topicName=适应性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b13a20191510, createdName=huhuaidong394, createdTime=Wed Dec 14 14:12:00 CST 2011, time=2011-12-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1684367, encodeId=8fa8168436eb1, content=<a href='/topic/show?id=dfae5133e1d' target=_blank style='color:#2F92EE;'>#心肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51337, encryptionId=dfae5133e1d, topicName=心肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e128082444, createdName=aids222, createdTime=Fri Feb 24 00:12:00 CST 2012, time=2012-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442790, encodeId=53971442e90ea, content=<a href='/topic/show?id=4198633567d' target=_blank style='color:#2F92EE;'>#死亡危险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63356, encryptionId=4198633567d, topicName=死亡危险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63604994803, createdName=1696533704_45270455, createdTime=Wed Dec 14 14:12:00 CST 2011, time=2011-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556382, encodeId=92a0155638261, content=<a href='/topic/show?id=1f525136920' target=_blank style='color:#2F92EE;'>#心肺适应性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51369, encryptionId=1f525136920, topicName=心肺适应性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dceb14754757, createdName=cnxcy, createdTime=Wed Dec 14 14:12:00 CST 2011, time=2011-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620990, encodeId=aaf216209907a, content=<a href='/topic/show?id=dccc94e01c9' target=_blank style='color:#2F92EE;'>#适应性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94701, encryptionId=dccc94e01c9, topicName=适应性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b13a20191510, createdName=huhuaidong394, createdTime=Wed Dec 14 14:12:00 CST 2011, time=2011-12-14, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1684367, encodeId=8fa8168436eb1, content=<a href='/topic/show?id=dfae5133e1d' target=_blank style='color:#2F92EE;'>#心肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51337, encryptionId=dfae5133e1d, topicName=心肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e128082444, createdName=aids222, createdTime=Fri Feb 24 00:12:00 CST 2012, time=2012-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442790, encodeId=53971442e90ea, content=<a href='/topic/show?id=4198633567d' target=_blank style='color:#2F92EE;'>#死亡危险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63356, encryptionId=4198633567d, topicName=死亡危险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63604994803, createdName=1696533704_45270455, createdTime=Wed Dec 14 14:12:00 CST 2011, time=2011-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556382, encodeId=92a0155638261, content=<a href='/topic/show?id=1f525136920' target=_blank style='color:#2F92EE;'>#心肺适应性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51369, encryptionId=1f525136920, topicName=心肺适应性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dceb14754757, createdName=cnxcy, createdTime=Wed Dec 14 14:12:00 CST 2011, time=2011-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620990, encodeId=aaf216209907a, content=<a href='/topic/show?id=dccc94e01c9' target=_blank style='color:#2F92EE;'>#适应性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94701, encryptionId=dccc94e01c9, topicName=适应性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b13a20191510, createdName=huhuaidong394, createdTime=Wed Dec 14 14:12:00 CST 2011, time=2011-12-14, status=1, ipAttribution=)]
Baidu
map
Baidu
map
Baidu
map